Atlas Trials

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

Clinical trial NCT04855656 · RECRUITING

Trial details

NCT number
NCT04855656
Sponsor
Debiopharm International SA
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Solid Tumor
Start date
2021-04-30
Primary completion
2027-12-01
Enrollment
464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.